JZMed, Inc.

JZMed, Inc. is a world leading pharmaceutical outsourcing service provider specializing in a full scale service for pharmaceutical outsourcing in China. It also provides market research services to companies who wish to enter the Chinese pharmaceuticals market or collaborate with Chinese pharmaceutical companies or Chinese pharmaceutical service companies.
JZMed, Inc.
 

List of reports from JZMed, Inc.

< prev 1    
Deciphering Global Major Pharma Companies’ New China Strategies (Second Edition) R&D, Manufacturing, and Product Marketing
3/1/2014 | published by: JZMed, Inc.
... fast growth of its economy for more than two decades has boosted the growth of the pharmaceutical market in the country. Besides the large size of its population, which determines the solid demand and large ...  |  read more...
$3,485.00
Re-evaluating the Attractions of Chinese Pharmaceutical Market and Chinese Pharmaceutical Industry & Market Growth Potentials, Innovative Drug R&D, and Manufacturing Capabilities and Capacities
3/1/2014 | published by: JZMed, Inc.
... attractions to all global pharmaceutical companies. In the past China used to be considered as a low cost destination by the global drug companies for pharmaceutical raw material supply. However, the fast growth of its ...  |  read more...
$3,485.00
Comparison of Innovative Drug R&D between China and India
1/1/2014 | published by: JZMed, Inc.
... enhanced experiences in biotechnology and drug R&D, including research on innovative medicines. A large number of drug R&D-focused biotech companies have been emerging in these two countries in the recent years. Although still young at ...  |  read more...
$3,485.00
Innovative Drug R&D in China (Second Edition) New Developments and Future Prospect
1/1/2014 | published by: JZMed, Inc.
... global drug companies that conduct R&D in China, a healthy R&D environment is being formed in China in the recent years. It has been fostering the growth of a large number of Chinese organizations, including ...  |  read more...
$3,485.00
The New Trends of Global Drug Discovery Outsourcing
9/1/2013 | published by: JZMed, Inc.
... to refocus on early stage pipelines. Drug discovery has thus regained the focus of all major pharma and biopharma companies. However, their research strategy in this field has undergone significant changes over the last couple ...  |  read more...
$3,485.00
Outlook of India Biopharmaceutical Outsourcing Market
7/1/2013 | published by: JZMed, Inc.
... decade, and the dramatic changes in R&D strategies have accordingly been taking place in all global major pharma and biopharma companies. All these drug companies have been steadily increasing their investment in biologic drug R&D ...  |  read more...
$3,285.00
Outlook of China Biopharmaceutical Outsourcing Market
7/1/2013 | published by: JZMed, Inc.
... interested to conduct biologic drug R&D and manufacturing in China in addition to marketing their products in the country. Their entrance and further expansion of their local presence also prompt them to seek services from ...  |  read more...
$3,285.00
Biopharmaceutical Outsourcing Opportunities in China and India Biologic Drug Discovery and Biopharmaceutical Manufacturing
7/1/2013 | published by: JZMed, Inc.
... fast growth in the recent decade. It has prompted all global major pharma and biopharma companies to increase their investment in biologics. Their R&D strategies have thus been changed dramatically in the recent years. Today, ...  |  read more...
$3,485.00
Biologic Drug R&D in China - Current State and Future Development
5/1/2013 | published by: JZMed, Inc.
... biological medicines. In the recent several years growing numbers of Chinese pharma and biopharma companies have been steadily increasing their investment in innovative drug R&D, including the discovery and development of novel biologics. The current ...  |  read more...
$3,685.00
Comparison of Biopharmaceutical Industry between China and India
3/1/2013 | published by: JZMed, Inc.
... untreatable diseases. The fast growth of the global biopharmaceutical market has prompted all global major pharma companies to increase their investment in biopharmaceuticals, which has resulted in a dramatic change in their R&D strategy and ...  |  read more...
$4,285.00
China Pharma Outsourcing Market by 2020
1/1/2013 | published by: JZMed, Inc.
... with other unique features, such as a large pool of talents who possess the desired technical skills and the required service capabilities, has made China one of the most favored destinations around the world for ...  |  read more...
$4,285.00
Analysis of Top 5 Chinese CROs
12/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$1,985.00
Chinese CRO Company Report - Pharmaron
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$395.00
Chinese CRO Company Report - Tigermed Consulting Co., Ltd.
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$395.00
Chinese CRO Company Report - WuXi PharmaTech
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$395.00
Chinese CRO Company Report - ShangPharma
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$395.00
Chinese CRO Company Report - Beijing Genomic Institute (BGI)
11/1/2012 | published by: JZMed, Inc.
... as competent as those top tier players in the same service sector of the global pharma outsourcing industry. To help global pharma outsourcing companies and professional service providers as well as venture capital investors better ...  |  read more...
$395.00
The New Trends of Drug Discovery Outsourcing in China and India
9/1/2012 | published by: JZMed, Inc.
... in the areas related to drug R&D, which makes each country unique for certain types of outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India each actually ...  |  read more...
$4,285.00
The New Trends of Drug Development Outsourcing in China and India
9/1/2012 | published by: JZMed, Inc.
... in the areas related to drug R&D, which makes each country unique for certain types of outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India each actually ...  |  read more...
$4,285.00
The New Trends of Drug R&D Outsourcing in China and India
9/1/2012 | published by: JZMed, Inc.
... in the areas related to drug R&D, which makes each country unique for certain types of drug R&D outsourcing activities. Although multinational drug companies now could have more choices than ever before, China and India ...  |  read more...
$6,885.00
Comparisons of Pharmaceutical Manufacturing between China and India
4/1/2012 | published by: JZMed, Inc.
... the balances between innovative drugs and generic drugs in their product portfolios and between the developed markets and the emerging markets in their market focuses. As a result, almost all pharma companies have been gradually ...  |  read more...
$4,285.00
China Pharma Outsourcing Annual Review 2011
2/1/2012 | published by: JZMed, Inc.
... this Chinese market has been well in line with our predictions. Prompted by the enormous interest of professionals in a variety of industries in this Chinese market and our obligation to best meet their demand, ...  |  read more...
$1,985.00
Outlook of China Drug Formulation Market
5/1/2011 | published by: JZMed, Inc.
... industry has existed in China for decades and growing numbers of Chinese drug companies are currently focusing on this area, their current technical skills and capability are still limited. However, as the fast growing Chinese ...  |  read more...
$3,285.00
China Pharma Outsourcing Annual Review 2010
2/1/2011 | published by: JZMed, Inc.
... development of this Chinese industry has been well in line with our predictions. Now that the industry has just entered a new year, many organizations and professionals around the world have started wondering again how ...  |  read more...
$695.00
Outlook of China Genomics and Proteomics Market - Application in Molecular Biomarker, Diagnostics and Personalized Medicine
1/1/2011 | published by: JZMed, Inc.
... Their efforts are leading to the gradual realization of personalized medicines. On the surface, what drive the gradual realization of personalized medicines are the technologies developed in molecular biomarker and diagnostics. However, it’s the genomics ...  |  read more...
$3,285.00
< prev 1    
 
US: 800.298.5699
Int'l: +1.240.747.3093
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!